Interested in Connecting? Please contact: James Carpenter CEO email@example.com
Message the company or request a 1:1 meeting here.
10% of newborn babies need stabilisation or resuscitation at delivery. Clinical guidelines say that vital signs, in particular heart rate, are the way to determine the course of treatment. However existing vital sign technologies do not work well in this setting and so clinicians often fall back on the stethoscope, but this is significantly inaccurate in 1 in 3 assessments. Incorrect treatment in these critical moments can have catastrophic consequences for babies and their families. At SurePulse, our vision is to revolutionise newborn vital sign monitoring and give clinicians and healthcare providers the tools to provide optimal newborn care. Our first product is a patented and CE approved accurate wireless heart rate monitor specifically designed for newborn babies. It consists of an optical sensor integrated into a soft cap which communicates with a display. Giving healthcare providers a clear upfront heart rate allows them to make confident decisions when every second counts.